In the 6-week studies, 80% of patients were aged 65 years or older1
In the 6-week studies, no differences in safety were reported based on age, gender, or MMSE score
27% had mild cognitive impairment (MMSE 21-24)
The maximum age in the clinical studies was 90 years2
MMSE=Mini-Mental State Examination.
Safety profile demonstrated in placebo-controlled studies1
*Based on 6-week placebo-controlled studies.